| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Preclinical Pharmacology |
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461 [L. A. M., H. M. M., D. L. R., C-P. H. Y., S. B. H.]; Laboratory of Bioorganic Chemistry, Sloan-Kettering Institute for Cancer Research, New York, New York 10021 [D. M., T. R. R. P., S. J. D.]; and Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6323 [M. D. K., H. A., A. B. S.]
Recently, three natural products have been identified, the epothilones, eleutherobin, and discodermolide, whose mechanism of action is similar to that of Taxol in that they stabilize microtubules and block cells in the mitotic phase of the cell cycle. In this report, we have compared and contrasted the effects of these new agents in Taxol-sensitive and -resistant cell lines. We also have taken advantage of a human lung carcinoma cell line, A549-T12, that was isolated as a Taxol-resistant cell line and found to require low concentrations of Taxol (2–6 nM) for normal cell division. This study then examined the ability of these new compounds to substitute for Taxol in sustaining the growth of A549-T12 cells. Immunofluorescence and flow cytometry have both indicated that the epothilones and eleutherobin, but not discodermolide, can substitute for Taxol in this Taxol-dependent cell line. In A549-T12 cells, the presence of Taxol significantly amplified the cytotoxicity of discodermolide, and this phenomenon was not observed in combinations of Taxol with either the epothilones or eleutherobin. Median effect analysis using the combination index method revealed a schedule-independent synergistic interaction between Taxol and discodermolide in four human carcinoma cell lines, an effect that was not observed between Taxol and epothilone B. Flow cytometry revealed that concurrent exposure of A549 cells to Taxol and discodermolide at doses that do not induce mitotic arrest caused an increase in the hypodiploid population, thereby indicating that a possible mechanism for the observed synergy is the potentiation of apoptosis. Our results suggest that Taxol and discodermolide may constitute a promising chemotherapeutic combination.
This article has been cited by other articles:
|
|
 |
|
  T. H. Davis Profile of Susan Band Horwitz PNAS, July 5, 2006; 103(27): 10163 - 10165. [Full Text] [PDF]
|
|
|
|
 |
|
 W.-Q. Ding, B. Liu, J. L. Vaught, R. D. Palmiter, and S. E. Lind Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol. Cancer Ther., July 1, 2006; 5(7): 1864 - 1872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Arai, Y. Matsumoto, Y. Nagashima, and K. Yagasaki Regulation of Class II {beta}-Tubulin Expression by Tumor Suppressor p53 Protein in Mouse Melanoma Cells in Response to Vinca Alkaloid Mol. Cancer Res., April 1, 2006; 4(4): 247 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Y. Yamada and G. J. Gorbsky Inhibition of TRIP1/S8/hSug1, a component of the human 19S proteasome, enhances mitotic apoptosis induced by spindle poisons Mol. Cancer Ther., January 1, 2006; 5(1): 29 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Huang, L. Lopez-Barcons, B. S. Freeze, A. B. Smith III, G. L. Goldberg, S. B. Horwitz, and H. M. McDaid Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice Clin. Cancer Res., January 1, 2006; 12(1): 298 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-D. Wu, Y. S. Cho, J. Katz, V. Ponomarev, S. Chen-Kiang, S. J. Danishefsky, and M. A. S. Moore Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo PNAS, July 26, 2005; 102(30): 10640 - 10645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-P. H. Yang, P. Verdier-Pinard, F. Wang, E. Lippaine-Horvath, L. He, D. Li, G. Hofle, I. Ojima, G. A. Orr, and S. B. Horwitz A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence Mol. Cancer Ther., June 1, 2005; 4(6): 987 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Marcus, U. Peters, S. L. Thomas, S. Garrett, A. Zelnak, T. M. Kapoor, and P. Giannakakou Mitotic Kinesin Inhibitors Induce Mitotic Arrest and Cell Death in Taxol-resistant and -sensitive Cancer Cells J. Biol. Chem., March 25, 2005; 280(12): 11569 - 11577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Dai, Y.-H. Ling, M. Lia, Y.-Y. Zou, G. Kroog, K. K. Iwata, and R. Perez-Soler Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell Lines Clin. Cancer Res., February 15, 2005; 11(4): 1572 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Honore, K. Kamath, D. Braguer, S. B. Horwitz, L. Wilson, C. Briand, and M. A. Jordan Synergistic Suppression of Microtubule Dynamics by Discodermolide and Paclitaxel in Non-Small Cell Lung Carcinoma Cells Cancer Res., July 15, 2004; 64(14): 4957 - 4964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Gapud, R. Bai, A. K. Ghosh, and E. Hamel Laulimalide and Paclitaxel: A Comparison of Their Effects on Tubulin Assembly and Their Synergistic Action When Present Simultaneously Mol. Pharmacol., July 1, 2004; 66(1): 113 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Honore, K. Kamath, D. Braguer, L. Wilson, C. Briand, and M. A. Jordan Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation Mol. Cancer Ther., December 1, 2003; 2(12): 1303 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Tinley, D. A. Randall-Hlubek, R. M. Leal, E. M. Jackson, J. W. Cessac, J. C. Quada Jr., T. K. Hemscheidt, and S. L. Mooberry Taccalonolides E and A: Plant-derived Steroids with Microtubule-stabilizing Activity Cancer Res., June 15, 2003; 63(12): 3211 - 3220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Martello, P. Verdier-Pinard, H.-J. Shen, L. He, K. Torres, G. A. Orr, and S. B. Horwitz Elevated Levels of Microtubule Destabilizing Factors in a Taxol-resistant/dependent A549 Cell Line with an {alpha}-Tubulin Mutation Cancer Res., March 15, 2003; 63(6): 1207 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Minguez, K. A. Giuliano, R. Balachandran, C. Madiraju, D. P. Curran, and B. W. Day Synthesis and High Content Cell-based Profiling of Simplified Analogues of the Microtubule Stabilizer (+)-Discodermolide Mol. Cancer Ther., December 1, 2002; 1(14): 1305 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. He, C.-P. Huang Yang, and S. B. Horwitz Mutations in {beta}-Tubulin Map to Domains Involved in Regulation of Microtubule Stability in Epothilone- resistant Cell Lines Mol. Cancer Ther., November 1, 2001; 1(1): 3 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Goncalves, D. Braguer, K. Kamath, L. Martello, C. Briand, S. Horwitz, L. Wilson, and M. A. Jordan Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics PNAS, September 13, 2001; (2001) 191388598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-P. H. Yang and S. B. Horwitz Taxol Mediates Serine Phosphorylation of the 66-kDa Shc Isoform Cancer Res., September 1, 2000; 60(18): 5171 - 5178. [Abstract] [Full Text]
|
|
|
|
|
|
P. Giannakakou and T. Fojo Discodermolide: Just Another Microtubule-stabilizing Agent? No! A Lesson in Synergy Clin. Cancer Res., May 1, 2000; 6(5): 1613 - 1615. [Full Text]
|
|
|
|
|
|
A. Goncalves, D. Braguer, K. Kamath, L. Martello, C. Briand, S. Horwitz, L. Wilson, and M. A. Jordan Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics PNAS, September 25, 2001; 98(20): 11737 - 11742. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
